By James Talcott, MD, SM, senior medical director, Oncology for Eviti, NantHealth.
A recent study from the Journal of the American Medical Association reported that while the U.S. spends nearly two times more per capita on cancer treatments, related mortality rates were only nominally lower. The analysis was a cross-sectional review of 22 high-income countries assessing the correlation between cancer treatment expenditures and 2020-associated fatalities.
In fact, nine of those listed—countries that invested significantly less in cancer care—have lower mortality rates. This study proposes an interesting new perspective: increased spending does not guarantee better results.
So how, then, can we optimize care? As new cancer treatments are constantly emerging, it can become overwhelming for providers to sift through data and treatment options to find the most appropriate—and cost-effective—plan for patients. Oftentimes, patients see quicker and more efficacious results when directed to the right treatment plan early on. This is where early intervention and treatment-validation technology becomes a key factor in optimized cancer care.
Improved Visibility and Patient Empowerment
Treatment-validation technology connects payers and providers, offering access to an advanced research library platform supplying tools and data analytics for the delivery of high-quality care. Clinicians can view thousands of proven treatment regimens, federally registered clinical trials, expected treatment outcomes, and predicted costs, all during the process of curating the best plan for their patients.
The ultimate goal in cancer care is singling out the most efficient and direct treatment plan—bypassing lengthy (and often costly) trial and error methods. In addition, when the patient is empowered with options and stated preferences, based on provider information, they help gain an understanding of the benefits as well as potential side effects of available treatments. This builds and promotes important conversations between them and their physician about their treatment course ahead.